Keywords: genta, unveils, long-term, genasense, trial, data, usa-based

Genta unveils long-term Genasense trial data

Article | 16 October 2006

Print This

USA-based biopharmaceutical company Genta says that data from a Phase III trial of its anticancer agent Genasense (oblimersen sodium), used ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in